Domain > www.promisneurosciences.com

More information on this domain is in AlienVault OTX

DNS Resolutions

Date	IP Address
2021-12-15	52.23.24.89 (ClassC)
2022-02-14	3.225.74.242 (ClassC)
2022-06-14	3.227.160.79 (ClassC)
2023-01-22	3.92.153.22 (ClassC)
2023-06-04	54.204.13.102 (ClassC)
2023-06-04	54.85.217.93 (ClassC)
2023-10-15	54.145.232.231 (ClassC)
2024-07-19	44.209.57.54 (ClassC)
2024-12-13	34.232.252.169 (ClassC)
2025-07-05	34.236.86.94 (ClassC)
2025-08-14	35.171.156.239 (ClassC)
2025-10-16	13.52.39.81 (ClassC)
2025-12-27	52.52.181.16 (ClassC)
2026-01-04	52.53.61.56 (ClassC)
2026-02-24	52.52.175.53 (ClassC)

HTTP/1.1 200 OKDate: Thu, 16 Oct 2025 05:15:02 GMTServer: ApacheX-Frame-Options: SAMEORIGINStrict-Transport-Security: max-age31536000;X-XSS-Protection: 1; modeblockX-Content-Type-Options: nosniffFeatu

!DOCTYPE html>html langen>    head>        meta http-equivx-ua-compatible contentieedge>        meta charsetutf-8>                        link relalternate typeapplication/rss+xml titleProMIS Neurosciences, Inc. - Recent News hrefhttps://www.promisneurosciences.com/news-media/press-releases/rss />                        title>ProMIS Neurosciences, Inc. (PMN)/title>                link relcanonical hrefhttps://www.promisneurosciences.com>meta propertyog:url contenthttps://www.promisneurosciences.com>meta propertyog:site_name contentProMIS Neurosciences, Inc.>meta propertyog:title contentProMIS Neurosciences, Inc.>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://d1io3yog0oux5.cloudfront.net/_5f8f55e75b61dc7a8eaefb63c26e0b8f/promisneurosciences/db/950/7857/social_image_resized.jpg>meta nametwitter:card contentsummary_large_image>script typeapplication/ld+json>	{@context:http://schema.org,@type:Corporation,name:ProMIS Neurosciences, Inc.,address:{@type:PostalAddress,streetAddress:1920 Yonge Street Suite 200,addressLocality:Toronto, ON,postalCode:M4S 3E2,addressCountry:Canada},legalName:ProMIS Neurosciences, Inc.,description:ProMISu2122 Neurosciences, Inc. (Nasdaq: PMN), is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimeru2019s disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinsonu2019s disease (PD). The Company has offices in Toronto, Ontario, and Cambridge, Massachusetts.,tickerSymbol:: PMN,url:https://www.promisneurosciences.com,logo:https://d1io3yog0oux5.cloudfront.net/_5f8f55e75b61dc7a8eaefb63c26e0b8f/promisneurosciences/logo.png,image:https://d1io3yog0oux5.cloudfront.net/_5f8f55e75b61dc7a8eaefb63c26e0b8f/promisneurosciences/db/950/7857/social_image_resized.jpg,sameAs:}/script>        meta nameviewport contentinitial-scale1.0, widthdevice-width>                        link relpreconnect hrefhttps://d1io3yog0oux5.cloudfront.net>        lin

Subdomains

Date	Domain	IP
ir.promisneurosciences.com	2025-05-25	184.169.227.74
www.promisneurosciences.com	2025-10-16	13.52.39.81

View on OTX | View on ThreatMiner

Data with thanks to AlienVault OTX, VirusTotal, Malwr and others. [Sitemap]

Domain > www.promisneurosciences.com

Is this malicious?

DNS Resolutions

Port 443

Subdomains